RAC 2.20% $1.78 race oncology ltd

[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene, page-100

  1. 454 Posts.
    lightbulb Created with Sketch. 107
    "I could go on an absolute rampage here but I won’t"

    Ooo0o0o0 sp00ky! Thanks for sparing us, I'm sure you have a good enough understanding of Bisantrene's previous, on-going and upcoming clinical trials to show us where the consistent results show tiny leaks that no one has noticed.

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.